CDC recommends testing all sexually active monkeypox patients for HIV
The Centers for Disease Control and Prevention yesterday recommended clinicians test all sexually active patients with monkeypox symptoms for HIV and other sexually transmitted infections due to the risk for severe monkeypox in individuals with HIV and other immunocompromising conditions. Among other actions, the agency recommends clinicians consider early treatment with the antiviral drug tecovirimat for immunocompromised patients diagnosed with monkeypox.
Related News Articles
Headline
The California Department of Public Health Saturday reported the first known case of clade I mpox in the U.S. to the Centers for Disease Control and Prevention…
Headline
The World Health Organization Aug. 14 declared a global health emergency due to the recent mpox outbreak in Africa, the second mpox declaration in two years.…
Headline
As summer Pride parades and other large gatherings approach, Americans at high risk for mpox (monkeypox) exposure should ensure they are fully vaccinated with…
Headline
The Food and Drug Administration Friday authorized for emergency use a molecular test to detect mpox (formerly known as monkeypox) at the point of care in…
Headline
The Food and Drug Administration Friday authorized for emergency use a real-time polymerase chain reaction test to detect mpox (formerly known as…
Headline
In a study of men under age 50 who were eligible to receive the JYNNEOS vaccine to prevent monkeypox (mpox) during the U.S. outbreak this year, unvaccinated…